losartan and sm 346
losartan has been researched along with sm 346 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Gribakina, OG; Kolyvanov, GB; Litvin, AA; Seredin, SB; Zherdev, VP | 1 |
| Gribakina, OG; Kolyvanov, GB; Litvin, AA; Shevchenko, RV; Smirnov, VV; Zherdev, VP | 1 |
Other Studies
2 other study(ies) available for losartan and sm 346
| Article | Year |
|---|---|
[In vivo study of the pharmacokinetic interaction of afobazole and losartan (cytochrome CYP2C9 substrate)].
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enzyme Induction; Losartan; Male; Morpholines; Rats | 2013 |
[EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450].
Topics: Animals; Animals, Outbred Strains; Anti-Anxiety Agents; Area Under Curve; Benzimidazoles; Biotransformation; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inducers; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Imidazoles; Losartan; Male; Morpholines; Rats; Tetrazoles | 2015 |